We are a bioanalytical lab that has evolved the model for partnership in large molecule bioanalysis to benefit our customers and the patients they serve.
We understand the challenges COVID-19 has created for organizations in our industry.
BioAgilytix is committed to supporting our industry through this difficult time. Our labs are fully functional, and we are prepared to support any of your global bioanalytical laboratory and assessment needs.
Schedule a time to discuss your needs with our team today.
Our fully integrated GxP services are driven by your assay requirements and delivered by our veteran scientists – collaboratively, accurately, and on time.
Biomarkers
Immunogenicity
Pharmacokinetics & Pharmacodynamics (PK/PD)
Cell-Based Assays
Our team is comprised of recognized experts in effectively navigating complex and evolving opportunities for biotherapeutics innovation.
Biosimilars
Gene Therapy
Antibody Drug Conjugates (ADCs)
Immuno-oncology
Co-Hosted with Bioanalysis Zone
This webinar takes a closer look at:
Explore the BioAgilytix way of thinking. Visit our Resource Center to learn more about our scientists’ expertise through case studies, blogs, industry articles and other scientific resources.
Quick links to our latest content offerings:
April 7, 2020Webinar Sneak Peek: Accelerating Testing of Therapeutics to Neutralize Viral Infections
March 30, 2020Women in STEM: Discussing Technology with BioAgilytix’s Whitney Gonzales this #WomensHistoryMonth
December 12, 2019BioAgilytix Welcomes Dominic Marasco to Leadership Team as Chief Commercial Officer
November 4, 2019BioAgilytix Announces Acquisition of Boston-Based Clinical Research Organization Cambridge Biomedical
March 13, 2020Supporting CAR-T Development
December 6, 2019CRISPR-Cas9 Milestones: The First In Vivo Clinical Trial Is Now Underway
Services
Platforms
